COVID-19 Antibody Testing

Please join us Wednesday, May 13, for a complimentary webinar addressing issues related to COVID-19 antibody testing.

The FDA recently reversed course on its lax stance toward COVID-19 antibody test manufacturers due to inaccuracy, false claims, and fraud. The FDA is now requiring all tests to be validated and go through its emergency use authorization process. Healthcare entities, employers, and the public are trying to wade through information to determine which tests are FDA approved, their accuracy, and how to utilize the test results. To help navigate the issues related to antibody testing, we will discuss:

  • The modified FDA regulatory pathway requiring emergency use authorization
  • Which COVID-19 antibody tests are currently FDA authorized
  • How to identify if a COVID-19 antibody test has received FDA authorization
  • The litations and unknowns of the COVID-19 antibody tests
  • Considerations for employers and the public in utilizing test results in decision-making
  • Medicare flexibilities related to reimbursement of testing
  • Relevant employment laws and how employers can use test information


Agenda: WEDNESDAY, MAY 13, 2020
12:00-1:00 PM MDT


Speakers:
Kristy Kimball
Mickell Jimenez

Location: Webinar Only

Webinar Information:
Event address for attendees
Password: 1234

Questions? Please contact Laura Squyres.

DISCLAIMER

Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.